AHA Statement on New HRSA Drug Pricing Website

Tom Nickels
Executive Vice President
American Hospital Association

April 1, 2019

 

The AHA is pleased that, in response to our successful lawsuit, the Health Resources and Services Administration today launched a new website to shine needed light on 340B drug pricing, which the government has found lacking. This website will help make sure hospitals participating in the program are not being overcharged by drug companies and that instances of price gouging can be uncovered and penalties enforced. As prescription drug prices continue to skyrocket, the 340B program is as crucial as ever in helping hospitals provide access to health care services for patients in vulnerable communities.

 

###

 

Contact:       

 

Marie Johnson, (202) 626-2351 mjohnson@aha.org

aColin Milligan, (202) 638-5491 cmilligan@aha.org

Related Resources

Letter/Comment
Public
AHA comments to the Senate Committee on Health, Education, Labor & Pensions (HELP) on the revised version of bill (S.
Special Bulletin
Member
The Senate Committee on Health, Education, Labor and Pensions (HELP) released a revised version of the Lower Health Care Costs Act of 2019 (S.1895) –…
Testimony
Public
AHA testimony before the Senate Committee on Health, Education, Labor and Pensions on the Lower Health Care Costs Act.
Action Alert
Member
The Senate Committee on Health, Education, Labor and Pensions has released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation to…
Letter/Comment
The AHA today submitted comments to the Senate Health, Education, Labor and Pensions Committee on their bipartisan discussion draft legislation, the Lower…
AHA Center for Health Innovation Market Scan
To understand what’s really driving Amazon's moves in pharmacy, it’s important to know the back story of Amazon’s $750 million-plus acquisition of PillPack, an…